Key result
Patients with COVID-19 ARDS had a significantly higher prevalence of obesity compared to historical non-COVID-19 ARDS controls (73% vs 28%, p < 0.001) and required more intensive management.
Why the study?
To investigate patients' characteristics, management, and outcomes in the critically ill population admitted to the ICU for severe acute respiratory syndrome coronavirus disease 2019 pneumonia causing ARDS.
Do patients with COVID-19 ARDS have different characteristics, management requirements, and outcomes compared to patients with non-COVID-19 ARDS?
Case-Control (n=83)
No
Do patients with COVID-19 ARDS have different characteristics, management requirements, and outcomes compared to patients with non-COVID-19 ARDS?
Answers are grounded in this paper and cite their sources.
Severe COVID-19 pneumonia disproportionately affects obese patients and requires highly intensive ICU management, though survival rates are comparable to non-COVID-19 ARDS when adequately resourced.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lemyze et al. (2020) conducted a case-control in COVID-19 ARDS (n=83). COVID-19 ARDS vs. Non-COVID-19 ARDS was evaluated on Prevalence of obesity (BMI > 30 kg/m2) (p=<0.001). Patients with COVID-19 ARDS had a significantly higher prevalence of obesity compared to historical non-COVID-19 ARDS controls (73% vs 28%, p < 0.001) and required more intensive management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: